Kathryn WIlliams

PhD, MHSc (HumNutr), MPH, BHSc
Kathryn Williams is a global regulatory and market access strategist with extensive experience guiding biotech companies through complex FDA, EMA, MHRA, and TGA pathways. She supports LLS in shaping regulatory foresight and global expansion strategy, ensuring science-driven innovation is aligned with international standards and patient access priorities.
The experts

Our Scientific & Medical Advisory Board